- Trials with a EudraCT protocol (94)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (12)
94 result(s) found for: Methylphenidate.
Displaying page 1 of 5.
| EudraCT Number: 2010-023992-24 | Sponsor Protocol Number: MEMAP1 | Start Date*: 2011-08-26 | |||||||||||
| Sponsor Name:University of Leipzig | |||||||||||||
| Full Title: International randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate | |||||||||||||
| Medical condition: acute mania and hypomania (ICD-10: F30.0, F30.1, F31.0, F31.1) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) ES (Prematurely Ended) BE (Completed) HU (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-004664-46 | Sponsor Protocol Number: melmet | Start Date*: 2008-07-29 |
| Sponsor Name:No Sponsor | ||
| Full Title: Influence of methylphenidate on sleep and circadian rhythm in children with Attention-Deficit/Hyperactivity Disorder (ADHD) | ||
| Medical condition: Sleep disorders in Attention-Deficit/ Hyperactivity Disorder (ADHD) | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-003660-11 | Sponsor Protocol Number: 74817 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Accare | ||
| Full Title: Do effects of methylphenidate decline after long-term use? A double-blind, placebo-controlled cross-over study of effects of methylphenidate on cognitive functioning and real world behavior in trea... | ||
| Medical condition: Attention Deficit Hyperactivity Disorder (ADHD) | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-005146-55 | Sponsor Protocol Number: VUB-HUIS-002 | Start Date*: 2016-01-27 |
| Sponsor Name:Vakgroep Huisartsgeneeskunde Vrije Universiteit Brussel | ||
| Full Title: The effect of methylphenidate (Ritalin®) on the severity of stuttering. | ||
| Medical condition: Stuttering | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-003418-15 | Sponsor Protocol Number: SSP | Start Date*: 2012-10-23 |
| Sponsor Name:Medizinische Universität Wien | ||
| Full Title: Methylphenidate modified release as treatment option of MS-associated fatigue. A single-center randomized double-blind placebo-controlled trial. | ||
| Medical condition: Fatigue is a very common symptom in multiple sclerosis. Its management comprises nonpharmacologic approaches like exercise, cooling procedures and energy conservation programs and as second step ph... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-001950-33 | Sponsor Protocol Number: 15/0592 | Start Date*: 2018-01-19 | |||||||||||
| Sponsor Name:UCL | |||||||||||||
| Full Title: Methylphenidate versus placebo for fatigue in advanced cancer (MePFAC) | |||||||||||||
| Medical condition: Cancer-related fatigue | |||||||||||||
|
|||||||||||||
| Population Age: | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2013-004206-26 | Sponsor Protocol Number: VUB-HUIS-001 | Start Date*: 2014-02-10 |
| Sponsor Name:Vakgroep Huisartsgeneeskunde VUB | ||
| Full Title: The effect of methylphenidate (Ritalin ®) on the severity of stuttering. | ||
| Medical condition: stuttering | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-000502-40 | Sponsor Protocol Number: RHM CAN0380 | Start Date*: 2005-05-13 |
| Sponsor Name:Southampton University Hospitals Trust | ||
| Full Title: A thematic analysis of semi-structured interviews using a phenomenological approach into palliative care patients experiences of change in "fatigue" following treatment with methylphenidate – an ex... | ||
| Medical condition: Patients with cancer in palliative stage of their illness. Suffering from fatigue with or without decreased concentration, depression or drowsiness, who feel their fatigue is severe enough to decre... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-004053-76 | Sponsor Protocol Number: NL73102.018.20 | Start Date*: 2020-12-10 |
| Sponsor Name:Amsterdam UMC [...] | ||
| Full Title: Effectiveness of methylphenidate in children and adults with Smith Magenis syndrome and attention-deficit/hyperactivity disorder: An N-of-1 series | ||
| Medical condition: Smith Magenis syndrome | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-005073-28 | Sponsor Protocol Number: ParKMetil/001 | Start Date*: 2021-12-28 |
| Sponsor Name:Universidad Rey Juan Carlos | ||
| Full Title: Double-blind, randomized, crossover design for evaluation of efficacy and safety of methylphenidate in cognition in patients with Parkinson's disease using electrophysiological measures | ||
| Medical condition: Cognition | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-002096-14 | Sponsor Protocol Number: MF115 | Start Date*: 2015-08-28 |
| Sponsor Name:Sahlgrenska University Hospital | ||
| Full Title: Examine whether treatment with methylphenidate facilitates work rehabilitation for persons with long-term pain and mental fatigue after traumatic brain injury. | ||
| Medical condition: Long-term pain and mental fatigue after traumatic brain injury and work rehabilitation. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-012643-42 | Sponsor Protocol Number: 28119 | Start Date*: 2010-01-06 |
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: Freezing of gait in Parkinson's disease: in search of the underlying mechanism and the application of a new treatment option | ||
| Medical condition: Parkinson's disease, in particular the symptom Freezing of Gait | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-000925-60 | Sponsor Protocol Number: R1/11 | Start Date*: 2011-10-18 |
| Sponsor Name:Kungälv Hospital | ||
| Full Title: Effect of treatment with methylphenidate on mental fatigue (“brain fatigue”) and pain on persons who have suffered a traumatic brain injury or whip lash injury – a pilot study. | ||
| Medical condition: Mental fatigue after traumatic brain injury or whip-lash injury | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-003049-13 | Sponsor Protocol Number: 7347 | Start Date*: 2022-08-24 |
| Sponsor Name:Hôpitaux Universitaires de Strasbourg | ||
| Full Title: EEG-MRI study of the effect of methylphenidate on neural mechanisms in adult patients with ADHD with or without mood disorders: A randomized controlled trial versus placebo. | ||
| Medical condition: Attention Deficit Hyperactivity Disorder (ADHD) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FR (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-004815-22 | Sponsor Protocol Number: INDICES/WP2/01 | Start Date*: 2012-01-24 | |||||||||||
| Sponsor Name:Research Institute of Biological Psychiatry Sct. Hans | |||||||||||||
| Full Title: Individualised drug therapy based on pharmacogenomics: focus on carboxylesterase 1 (CES1) | |||||||||||||
| Medical condition: Healthy volunteers with special genotypes | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-002002-20 | Sponsor Protocol Number: 2014METAL1 | Start Date*: 2015-06-10 |
| Sponsor Name:UMCG | ||
| Full Title: A multicentre randomized double-blind placebo controlled discontinuation trial of methylphenidate | ||
| Medical condition: attention-deficit/hyperactivity disorder | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000992-18 | Sponsor Protocol Number: 12-016 | Start Date*: 2014-09-26 |
| Sponsor Name:UMC Utrecht | ||
| Full Title: Proactive versus reactive inhibition in ADHD: Genetics, neurobiology and pharmacology | ||
| Medical condition: Attention-Deficit Hyperactivity Disorder (ADHD) | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000492-17 | Sponsor Protocol Number: NL39440.029.10 | Start Date*: 2012-10-29 |
| Sponsor Name:Afdeling Klinische Neuropsychologie Vrije Universiteit Amsterdam | ||
| Full Title: The Effects of Long-acting Methylphenidate on Academic Activity and Related Constructs in Children with ADHD: A Randomised Placebo Controlled Trial | ||
| Medical condition: Attention-deficit hyperactivity disorder (ADHD) | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-002249-35 | Sponsor Protocol Number: mkjf001 | Start Date*: 2006-10-26 |
| Sponsor Name:Addiction Center Stockholm | ||
| Full Title: Clinical trial of sustained release methylphenidate for Attention-Deficit-Hyperactivity-Disorder (ADHD) in adult criminal offenders with amphetamine addiction | ||
| Medical condition: 54 male prison inmates (27 in each treatment condition) that meet the DSM-IV criteria for amphetamine addiction and for ADHD and who are servicing their prison sentence are recruited. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-004298-20 | Sponsor Protocol Number: MAMCAC02102014 | Start Date*: 2015-02-03 |
| Sponsor Name:Stockholm Centre for Dependency Disorders | ||
| Full Title: The effect of methylphenidate on executive functioning in amphetamine dependent individuals with ADHD | ||
| Medical condition: Amphetamine dependence | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
